Brief: Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement
04/12/2025 14:19
Dec 4 (Reuters) - Pelthos Therapeutics Inc PTHS.A: PELTHOS THERAPEUTICS SIGNS MAJOR PHARMACY BENEFIT MANAGER AGREEMENT EXPANDING PATIENT ACCESS TO ZELSUVMI™ (BERDAZIMER) TOPICAL GEL, 10.3% Source text: ID:nGNX5fq8vs Further company coverage: PTHS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pelthos Therapeutics
See all newsPelthos Therapeutics falls as co says will restate Q1 financial statements
Brief: Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
Pelthos Therapeutics Q2 revenue rises on Zelsuvmi adoption
Brief: Pelthos Therapeutics Announces CFO Transition
Brief: Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye Pain